Cardiol Therapeutics is a nanotherapeutics company focusing on research and commercial development of proprietary drug formulations for the treatment of heart failure and cancer. Co. produces pharmaceutical cannabidiol ("CBD") products and develops innovative therapies for heart disease, including acute myocarditis and other causes of heart failure. Co.'s lead product, CardiolRx, is designed to be the safest and most consistent CBD formulation on the market. CardiolRx is pharmaceutically produced, cGMP certified, and does not contain any THC. We show 1 historical shares outstanding datapoints in our CRDL shares outstanding history coverage, used to compute CRDL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CRDL market cap history over the course of time is important for investors
interested in comparing CRDL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CRDL versus a peer is one thing; comparing
CRDL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CRDL can fluctuate over the course of history.
With this page we aim to empower investors researching CRDL by allowing them to research the CRDL market cap history. |
Free CRDL Email Alerts:
Video: The Importance of Market Cap
